4//SEC Filing
GENOCEA BIOSCIENCES, INC. 4
Accession 0000904454-14-000596
CIK 0001457612operating
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 4:10 PM ET
Size
6.9 KB
Accession
0000904454-14-000596
Insider Transaction Report
Form 4
HETHERINGTON SETH V
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2014-08-18$2.02/sh+11,000$22,220→ 11,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-08-18−11,000→ 2,989 totalExercise: $2.02Exp: 2021-02-16→ Common Stock (11,000 underlying)
Footnotes (1)
- [F1]The option vested in full upon the satisfaction of certain milestone performance criteria, in accordance with the Issuer's 2007 Equity Plan.
Documents
Issuer
GENOCEA BIOSCIENCES, INC.
CIK 0001457612
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001457612
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 4:10 PM ET
- Size
- 6.9 KB